D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Fulgent Genetics
FLGT
$670M
| $730K | ﹤0.01% |
+11,700
| New | +$730K |
|
2877
MYR Group
MYRG
$2.73B
| $729K | ﹤0.01% |
7,750
-1,571
| -17% | -$148K |
|
2878
Adeia
ADEA
$1.71B
| $727K | ﹤0.01% |
+158,590
| New | +$727K |
|
2879
Eagle Bancorp
EGBN
$615M
| $725K | ﹤0.01% |
12,718
+2,864
| +29% | +$163K |
|
2880
Establishment Labs
ESTA
$1.09B
| $722K | ﹤0.01% |
+10,716
| New | +$722K |
|
2881
Alaunos Therapeutics
TCRT
$5.1M
| $722K | ﹤0.01% |
7,378
+975
| +15% | +$95.4K |
|
2882
Spire Global
SPIR
$307M
| $721K | ﹤0.01% |
42,905
+18,262
| +74% | +$307K |
|
|
AWH
2883
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $720K | ﹤0.01% |
46,122
+5,672
| +14% | +$88.5K |
|
2884
ResMed
RMD
$39.6B
| $715K | ﹤0.01% |
2,948
+99
| +3% | +$24K |
|
2885
Empire State Realty Trust
ESRT
$1.34B
| $714K | ﹤0.01% |
+72,676
| New | +$714K |
|
2886
dLocal
DLO
$4.03B
| $713K | ﹤0.01% |
22,803
+9,448
| +71% | +$295K |
|
2887
Rayonier
RYN
$4.05B
| $708K | ﹤0.01% |
18,101
+778
| +4% | +$30.4K |
|
2888
Midland States Bancorp
MSBI
$385M
| $706K | ﹤0.01% |
24,477
-21,014
| -46% | -$606K |
|
2889
Fidus Investment
FDUS
$760M
| $703K | ﹤0.01% |
34,857
+23,944
| +219% | +$483K |
|
|
MODN
2890
DELISTED
MODEL N, INC.
MODN
| $703K | ﹤0.01% |
26,152
+11,426
| +78% | +$307K |
|
2891
CTS Corp
CTS
$1.23B
| $702K | ﹤0.01% |
19,866
-25,693
| -56% | -$908K |
|
2892
Ardelyx
ARDX
$1.59B
| $700K | ﹤0.01% |
654,048
+533,273
| +442% | +$571K |
|
2893
Burford Capital
BUR
$2.82B
| $700K | ﹤0.01% |
76,106
+31,649
| +71% | +$291K |
|
2894
Nerdy
NRDY
$158M
| $698K | ﹤0.01% |
137,084
-249,840
| -65% | -$1.27M |
|
|
JNPR
2895
DELISTED
Juniper Networks
JNPR
| $695K | ﹤0.01% |
+18,700
| New | +$695K |
|
|
MZTI
2896
The Marzetti Company Common Stock
MZTI
$5.04B
| $695K | ﹤0.01% |
4,662
+3,366
| +260% | +$502K |
|
2897
M/I Homes
MHO
$4.07B
| $695K | ﹤0.01% |
15,682
+1,789
| +13% | +$79.3K |
|
|
PDM
2898
Piedmont Realty Trust, Inc.
PDM
$1.1B
| $695K | ﹤0.01% |
40,350
+24,756
| +159% | +$426K |
|
2899
TELUS International
TIXT
$1.25B
| $692K | ﹤0.01% |
28,015
+16,861
| +151% | +$416K |
|
2900
Novanta
NOVT
$4.12B
| $691K | ﹤0.01% |
4,859
-86
| -2% | -$12.2K |
|